XML 47 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and Other Purchased Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes to goodwill by segment
Changes to goodwill by segment were as follows (in millions):
 20232022
Life
Science
Clinical
Diagnostics
TotalLife
Science
Clinical
Diagnostics
Total
Balances as of January 1:      
Goodwill$333.3 $408.4 $741.7 $333.3 $349.2 $682.5 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net291.5 115.0 406.5 291.5 55.8 347.3 
Acquisitions
— 0.4 0.4 — 55.9 55.9 
Foreign currency adjustments— 6.7 6.7 — 3.3 3.3 
Period increase, net— 7.1 7.1 — 59.2 59.2 
Balances as of December 31:      
Goodwill333.3 415.5 748.8 333.3 408.4 741.7 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net$291.5 $122.1 $413.6 $291.5 $115.0 $406.5 
Schedule of Finite-Lived Intangible Assets by Major-Class
Information regarding our identifiable purchased intangible assets with finite and indefinite lives is as follows (in millions):
December 31, 2023
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists5.2$108.7 $(98.9)$9.8 
Know how1.8168.9 (161.1)7.8 
Developed product technology12.0217.8 (132.9)84.9 
Licenses4.959.2 (42.4)16.8 
Tradenames5.66.1 (4.7)1.4 
Covenants not to compete2.36.4 (4.8)1.6 
     Total finite-lived intangible assets567.1 (444.8)122.3 
In-process research and development198.2 — 198.2 
     Total purchased intangible assets$765.3 $(444.8)$320.5 




 December 31, 2022
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists5.0$104.7 $(89.9)$14.8 
Know how2.8166.2 (153.9)12.3 
Developed product technology12.8211.1 (121.6)89.5 
Licenses5.859.0 (38.5)20.5 
Tradenames6.66.1 (4.5)1.6 
Covenants not to compete3.16.4 (4.0)2.4 
Total finite-lived intangible assets 553.5 (412.4)141.1 
In-process research and development191.0 — 191.0 
Total purchased intangible assets$744.5 $(412.4)$332.1